Nuveen Asset Management’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-144,336
| Closed | -$4.22M | – | 3516 |
|
2022
Q1 | $4.22M | Sell |
144,336
-20,470
| -12% | -$598K | ﹤0.01% | 2152 |
|
2021
Q4 | $4.36M | Sell |
164,806
-20,417
| -11% | -$540K | ﹤0.01% | 2202 |
|
2021
Q3 | $4.27M | Sell |
185,223
-33,382
| -15% | -$770K | ﹤0.01% | 2301 |
|
2021
Q2 | $5.75M | Sell |
218,605
-67,581
| -24% | -$1.78M | ﹤0.01% | 2178 |
|
2021
Q1 | $6.39M | Buy |
286,186
+67,381
| +31% | +$1.5M | ﹤0.01% | 2047 |
|
2020
Q4 | $4.29M | Buy |
218,805
+11,519
| +6% | +$226K | ﹤0.01% | 2152 |
|
2020
Q3 | $2.91M | Sell |
207,286
-61,276
| -23% | -$859K | ﹤0.01% | 2201 |
|
2020
Q2 | $3.04M | Sell |
268,562
-23,504
| -8% | -$266K | ﹤0.01% | 2153 |
|
2020
Q1 | $1.84M | Buy |
292,066
+5,066
| +2% | +$31.9K | ﹤0.01% | 2233 |
|
2019
Q4 | $5.84M | Sell |
287,000
-2,788
| -1% | -$56.7K | ﹤0.01% | 1902 |
|
2019
Q3 | $4.82M | Sell |
289,788
-416
| -0.1% | -$6.92K | ﹤0.01% | 1976 |
|
2019
Q2 | $4.77M | Buy |
290,204
+243,141
| +517% | +$4M | ﹤0.01% | 2019 |
|
2019
Q1 | $826K | Buy |
47,063
+574
| +1% | +$10.1K | ﹤0.01% | 769 |
|
2018
Q4 | $1.15M | Sell |
46,489
-927,108
| -95% | -$23M | 0.01% | 692 |
|
2018
Q3 | $31.3M | Buy |
973,597
+53,298
| +6% | +$1.71M | 0.17% | 183 |
|
2018
Q2 | $32.4M | Buy |
920,299
+107,510
| +13% | +$3.78M | 0.2% | 146 |
|
2018
Q1 | $32.2M | Buy |
812,789
+260,048
| +47% | +$10.3M | 0.21% | 145 |
|
2017
Q4 | $20.2M | Buy |
552,741
+61,068
| +12% | +$2.23M | 0.13% | 239 |
|
2017
Q3 | $20.1M | Buy |
491,673
+39,584
| +9% | +$1.62M | 0.13% | 237 |
|
2017
Q2 | $18M | Buy |
452,089
+168,382
| +59% | +$6.71M | 0.12% | 252 |
|
2017
Q1 | $8.26M | Buy |
+283,707
| New | +$8.26M | 0.05% | 455 |
|
2013
Q4 | – | Sell |
-140,053
| Closed | -$2.59M | – | 1552 |
|
2013
Q3 | $2.59M | Buy |
140,053
+112,657
| +411% | +$2.08M | 0.02% | 638 |
|
2013
Q2 | $476K | Buy |
+27,396
| New | +$476K | ﹤0.01% | 1251 |
|